Expression of Cyclooxygenase-1 and -2 in Human Breast Cancer

Surgery Today

Volumn 33, Issue 11, 2003, Pages 805-811

  Yoshimura, Norio ^a   Sano, Hajime ^a   Okamoto, Masahiko ^a   Akioka, Kiyokazu ^a   Ushigome, Hidetaka ^a   Kadotani, Yayoi ^a   Yoshimura, Rikio ^b   Nobori, Shuji ^a   Higuchi, Atsushi ^a   Ohmori, Yoshihiro ^a   Nakamura, Kenji ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b Osaka Prefecture University   (Japan)

Author keywords

Breast cancer; Cyclooxygenase 1; Cyclooxygenase 2; Fibroadenoma; Mastopathy

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; POLYPEPTIDE;

ADULT; AGED; ARTICLE; BENIGN TUMOR; BREAST; BREAST CANCER; BREAST DISEASE; CANCER CELL; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FIBROADENOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALIGNANT NEOPLASTIC DISEASE; MALIGNANT TRANSFORMATION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; BIOPSY, NEEDLE; BREAST NEOPLASMS; COHORT STUDIES; CULTURE TECHNIQUES; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; ISOENZYMES; MEMBRANE PROTEINS; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC; TUMOR MARKERS, BIOLOGICAL;

EID: 10744222191     PISSN: 09411291     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00595-003-2606-3     Document Type: Article

References (52)

1. Bicknell R, Harris AL. Novel growth regulatory factors and tumor angiogenesis. Eur J Cancer 1991;27:781-4.
2. Folkman J, Watson K, Ingber D, Hanahan D. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 1989;339:58-61.
3. Dickson RB, Thompson EW, Lippman ME. Regulation of proliferation, invasion and growth factor synthesis in breast cancer by steroids. J Steroid Biochem Mol 1990;37:305-16.
4. Freiss G, Prebois C, Vignon F. Control of breast cancer cell growth by steroids and growth factors: interaction and mechanisms. Breast Cancer Res Treat 1993;27:57-68.
5. Smith WL, Marnett LJ. Prostaglandin endoperoxide synthease: structure and catalysis. Biochim Biophys Acta 1991;1083:1-17.
6. Kujubu DA, Reddy ST, Fletcher BS, Herschman HR. Expression of the protein product of the prostaglandin synthase-2/TIS 10 gene in mitogen-stimulated Swiss 3T3 cells. J Biol Chem 1993; 268:5425-30.
7. Simmons DL, Xic W, Chipman JG, Evett GE. Multiple cyclooxygenase: cloning of a mitogen-inducible form. In: Bailey JM, editor. Prostaglandin, leukotrienes, lipoxins and PAF. New York: Plenum; 1991. p. 57-8.
8. 2 synthase in the endothelium and smooth muscle of bovine aorta. J Clin Invest 1983;72:1882-8.
9. Smith WL, Bell TG. Immunohistochemical localization of prostaglandin forming cyclooxyenase in renal cortex. Am J Physiol 1978;235:F451-7.
10. Dewitt DL, Smith WL. Primary structure of prostaglandin G/H synthase from sheep vesicular gland determined from the complementary DNA sequence. Proc Natl Acad Sci USA 1988;85:1412-6.
11. Funk CD, Funk LB, Kennedy ME, Pong AS, Fitzgerald GA. Human platelet/erythroleukemia cell prostaglandin G/H synthetase; cDNA cloning, expression, and gene chromosomal assignment. FASEB J 1991;5:2304-12.
12. Hla T, Neilson K. Human cyclooxygenase-2 cDNA. Proc Natl Acad Sci USA 1992;89:7384-8.
13. Kujubu DA, Fletcher BS, Varnium BC, Lim RW, Herschman HR. TS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostglandin synthase/cyclooxygenase homologue. J Biol Chem 1991;266:12866-72.
14. O'Banion MK, Winn VD, Young DA. cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase. Proc Natl Acad Sci USA 1992;89:4888-92.
15. Sano H, Hla T, Maier JAM, Crofford LJ, Case JP, Maciag T, et al. In vivo cyclooxygenase expression in synovial tissues of patients with rheumatoid arthritis and osteoarthritis and rats with adjuvant and streptococcal cell wall arthritis. J Clin Invest 1992:89:97-108.
16. Crofford LJ, Wilder RL, Ristimaki AP, Sano H, Remmers EF, Epps HR, et al. Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissues: effects of interleukin-1b, phorbol ester, and corticosteroids. J Clin Invest 1994;93:1095-101.
17. Dubois RN, Tsujii M, Bishop P, Awad JA, Makita K, Lanahan A. Cloning and characterization of a growth factor-inducible cyclooxygenase gene from rat intestinal epithelial cells. Am J Physiol 1994;266:G822-7.
18. Dubois RN, Awad J, Morrow J, Roberts LJ, Bishop PR. Regulation of eicosanoid production and mitogenesis in rat epithelial cells cell by transforming growth factor-α and phorbol esters. J Clin Invest 1994;93:493-8.
19. Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrebach S, Dubois RN. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 1994;107:1183-8.
20. Sano H, Kawahito Y, Wilder R. The expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res 1995;55:3785-9.
21. Kawahito Y, Sano H, Mukai S. Corticotoropin-releasing hormone in clonic mucosa in patients with ulcerative colitis. Gut 1995;37: 544-51.
22. Sano H, Engleka K, Mathern P, Hla T, Crofford LJ, Remmers EF, et al. Coexpression of platelet-derived growth factor-B, and fibroblast growth factor-1 in situ in synovial tissues of patients with rheumatoid arthritis and Lewis rats with adjuvant or streptococcal cell wall arthritis. J Clin Invest 1993;91:553-65.
23. Kawahito Y, Sano H, Kawata M, Yuri K, Mukai S, Yamamura Y, et al. Local secretion of corticotropin-releasing hormone by enterochromaffin cells in human colon. Gastroenterology 1994; 106:859-65.
24. Remingron RD, Schork MA. Statistics with applications to the biological and health science. New Jersey: Prentice-Hall; 1985. p. 415.
25. Japan Mammary Cancer Society. General rule for clinical and histological record of mammary cancer. Part II. Histological classification of mammary cancer. Jpn J Surg 1975;5:175-85.
26. Bosari J, Lee AKC, De Lellis RA, Wiley BD, Heatley GJ, Silverman ML. Microvessel quantitation and prognosis in invasive breast carcinoma. Hum Pathol 1992;23:755-61.
27. Weidner N, Folkman J, Pozza F, Bevilaqua P, Allred EN, Moore DH. Tumor angiogenesis: a new significant and independent prognostic indicator in early stage breast carcinoma. J Natl Cancer Inst 1992;84:1875-87.
28. Yoshimura N, Sano H, Hashiramoto A. The expression and localization of fibroblast growth factor-1 (FGF-1) and FGF receptor-1 (FGFR-1) in human breast cancer. Clin Immunol Immunopathol 2003;88: in press.
29. Lee SH, Soyoola E, Chanmugam P, Hart S, Sun W, Zhong H, et al. Selective expression of mitogen-inducible cyclooxygenase in macrophage stimulated with lipopolysaccharide. J Biol Chem 1992;26:25934-8.
30. Hempel SL, Monick MM, Hunninghake GW. Lipopolysaccharide induces prostaglandin H synthase-2 protein and mRNA in human alveolar macrophages and blood monocytes. J Clin Invest 1994;93:391-6.
31. Ristimaki A, Honkanen N, Jankala H, Sipponen P, Harkonen M. Expression of cyclooxygenase-2 in human gastric carcinoma. Cancer Res 1997;57:1276-80.
32. Tsujii M, DuBois RN. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 1995;83:493.
33. Xie W, Chipman JG, Robertson DL, Erikson RL, Simmons DL. Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc Natl Acad Sci USA 1991;88:2692-6.
34. Hwang D, Scollard D, Byme J, Levine E. Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer. J Natl Cancer Inst 1998;90:455-60.
35. Zimmmermann KC, Sarbia M, Weber AA, Borchard F, Gabbert HE, Schror K. Cyclooxygenase-2 expression in human esophageal carcinoma. Cancer Res 1999;59:198-204.
36. Hida T, Yatabe Y, Achiwa H, Muramatsu H, Kozaki K, Nakamura S. Increased expression of cyclooxygenase-2 occurs frequently in human lung cancers, specifically in adenocarcinomas. Cancer Res 1998;58:3761-4.
37. Koga H, Sakisaka S, Ohishi M, Kawaguchi T, Taniguchi E, Sasatomi K. Expression of cyclooxygenase-2 in human hepatocellular carcinoma: relevance to tumor dedifferentiation. Hepatology 1999;29:688-96.
38. Chan G, Boyle JO, Yang EK, Zhang F, Sacks PG, Shah JP. Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck. Cancer Res 1999;59:9914.
39. Tucker ON, Dannenberg AI, Yang EK, Zhang F, Teng L, Daly JM. Cyclooxygenase-2 expression in up-regulated in human pancreatic cancer. Cancer Res 1999;59:987-90.
40. Bennet A. In: Rose DP, editor. Endocrinology of breast cancer. vol. 3. Boca Raton: CRC Press; 1982. p. 113-27.
41. Karmali RA, Welt S, Thaler HT, Lifevre F. Prostaglandins in breast cancer. Relationship to disease stage and hormone status. Br J Cancer 1983;48:689-96.
42. Tan WC, Privett OS, Goldyne ME. Studies of prostaglandins in rat mammary tumors induces by 7,12-dimethylbenz(a) anthracene. Cancer Res 1974;34:3229-31.
43. Rolland PH, Martin PM. Prostaglandins et cancer du sein. J Gynecol Obstet Biol Reprod 1981;10:295-305.
44. Bennett A, Chalier EM, McDonald AM, Simpson JS, Stamford IF, Zebro T. Postaglandins and breast cancer. Lancet 1977;ii:624-6.
45. Rolland PH, Martin PM, Jacquemier J, Rolland AM, Toga M. Prostaglandin in human breast cancer. Evidence suggesting that elevated prostaglandin production is a marker of high metastatic potential for neoplastic cells. J Natl Cancer Inst 1980;64:1060-9.
46. Bennett A, Berstock DA, Raja B, Stamford RF. Survival time after surgery is inversely related to the amounts of prostaglandins extracted from human breast cancers. Br J Pharmacol 1979;66: 451.
47. Thompson HJ, Jiang C, Lu J, Mehta RG, Piazza GA, Paranka NS, et al. Sulfone metabolite of sulindac inhibits mammary carcinogenesis. Cancer Res 1997;57:267-71.
48. Harris RE, Namboodiri K, Farrar WB. Nonsteroidal anti-inflammatory drugs and breast cancer. Epidemiology 1996;7:203-5.
49. Marnett LJ. Polycyclic aromatic hydrocarbon oxidation during prostaglandin biosynthesis. Life Sci 1981;29:531-46.
50. Smith BJ, Curtis JF, Eling TE. Bioactivation of xenobiotics by prostaglandin H synthetase. Chem Biol Interact 1991;79:245-64.
51. Van Aswegen C, van Schalkwyk ICD, Roux LJ, Becker PJ, Du Plwssis DJ. A novel study on the effect of acetylsalicylic acid on the binding capacity of estrogen receptor from MCF-7 ce. Clin Physiol Biochem 1992;9:145-9.
52. Kopp E, Ghosh S. Inhibition of NF-kB by sodium salicylate and aspirin. Science 1994;265:956-9.